D Metcalf, N Nicola, 1995 - books.google.com The four hemopoietic colony-stimulating factors (CSFs) are the major regulators
in the body of the production and activity of two types of white blood cells -
granulocytes and macrophages. Since these cells are primar- ily responsible ... Cited by 665 - Related articles - All 2 versions
D Metcalf - Science (New York, NY), 1991 - ncbi.nlm.nih.gov The production and functional activity of two important white blood cells, the
granulocytes and macrophages, are regulated mainly by a group of glycoprotein
colony-stimulating factors. The colony-stimulating factors have been mass- ... Cited by 286 - Related articles - All 4 versions
DL Coleman - Reviews of Infectious Diseases, 1990 - jstor.org REVIEWS OF INFECTIOUS DISEASES * VOL. 12, NO. 1 * JANUARY-FEBRUARY 1990 ... ?
1990 by The University of Chicago. All rights reserved. 0612-0882/90/1201-0027
$02.00 ... From the Infectious Disease Section, Department of Medicine, ... Cited by 157 - Related articles - All 2 versions
- ►hematologylibrary.org - Free from Publisher RL Basser, JEJ Rasko, K Clarke, J Cebon, … - Blood, 1997 - bloodjournal.hematologylibrary.org Thrombocytopenia caused by chemotherapy is an important cause of morbidity and
mortality in the treatment of malignant disease. Recombinant human megakaryocyte
growth and development factor (PEG-rHuMGDF ) is a potent stimulator of ... Cited by 131 - Related articles - BL Direct - All 4 versions
- ►ascopubs.org [PDF] WP Steward, J Verweij, R Somers, D Spooner, … - Journal of Clinical Oncology, 1993 - jco.ascopubs.org Purpose: This study was designed to test the feasi- bility of administering
doxorubicin at an optimal dose- intensity (> 70 mg/m' per 21 days) in
combination with ifosfamide under recombinant human granulocyte-mac- ... Cited by 112 - Related articles - BL Direct - All 7 versions
- ►ascopubs.org [PDF] JM Vose, JO Armitage - Journal of Clinical Oncology, 1995 - jco.ascopubs.org Purpose and Design: To review the current clinical uses, ongoing investigations,
and future applications of hematopoietic growth factors. Approved cytokines, as
well as cytokines not yet released for general use, are included in this ... Cited by 93 - Related articles - BL Direct - All 6 versions
EJ Anaissie, S Vartivarian, GP Bodey, C … - The American journal of medicine, 1996 - Elsevier : Addition of rh-GMCSF to the antibiotics significantly improved the response
rate (96% versus 82%, P = 0.03), but not the survival rate (93% versus 93%), in
the evaluable patients. This difference in response rate was not ... Cited by 84 - Related articles - BL Direct - All 8 versions
E Roilides, PA Pizzo - Clinical Infectious Diseases, 1992 - jstor.org Traditional management of infectious complications, especially in
immunocompromised hosts, has depended on the prompt initiation of therapy with
broad-spectrum antibiotics. During the past several years, however, a ... Cited by 79 - Related articles - All 3 versions
MAS Moore - Annual Review of Immunology, 1991 - Annual Reviews Abstract Colony stimulating factors and interleukins regulate proliferation,
differ entiation, and functional activation of hematopoietic cells of multiple
lineages. These hematopoietic growth factors are proving effective in vivo ... Cited by 78 - Related articles - All 5 versions
